{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:19:47Z","timestamp":1762867187958},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1038\/sc.2017.94","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T09:20:46Z","timestamp":1502184046000},"page":"22-27","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effects of antimuscarinic treatment on the cognition of spinal cord injured individuals with neurogenic lower urinary tract dysfunction: a prospective controlled before-and-after study"],"prefix":"10.1038","volume":"56","author":[{"given":"J","family":"Krebs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Scheel-Sailer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Oertli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Pannek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"BFsc201794_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.eururo.2015.07.071","volume":"69","author":"J Groen","year":"2016","unstructured":"Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol. 2016; 69: 324\u2013333.","journal-title":"Eur Urol."},{"key":"BFsc201794_CR2","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1097\/00007632-200112151-00022","volume":"26","author":"AS Burns","year":"2001","unstructured":"Burns AS, Rivas DA, Ditunno JF . The management of neurogenic bladder and sexual dysfunction after spinal cord injury. Spine 2001; 26: S129\u2013S136.","journal-title":"Spine"},{"key":"BFsc201794_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrurol.2016.206","volume":"13","author":"JJ Wyndaele","year":"2016","unstructured":"Wyndaele JJ . The management of neurogenic lower urinary tract dysfunction after spinal cord injury. Nat Rev Urol 2016; 13: 705\u2013714.","journal-title":"Nat Rev Urol"},{"key":"BFsc201794_CR4","doi-asserted-by":"publisher","first-page":"e16718","DOI":"10.1371\/journal.pone.0016718","volume":"6","author":"TM Kessler","year":"2011","unstructured":"Kessler TM, Bachmann LM, Minder C, Lohrer D, Umbehr M, Schunemann HJ et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS ONE 2011; 6: e16718.","journal-title":"PLoS ONE"},{"key":"BFsc201794_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1755-5949.2011.00248.x","volume":"18","author":"M Chancellor","year":"2012","unstructured":"Chancellor M, Boone T . Anticholinergics for overactive bladder therapy: central nervous system effects. CNS Neurosci Ther 2012; 18: 167\u2013174.","journal-title":"CNS Neurosci Ther"},{"key":"BFsc201794_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40520-015-0359-7","volume":"28","author":"A Collamati","year":"2016","unstructured":"Collamati A, Martone AM, Poscia A, Brandi V, Celi M, Marzetti E et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res 2016; 28: 25\u201335.","journal-title":"Aging Clin Exp Res"},{"key":"BFsc201794_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","volume":"73","author":"SL Risacher","year":"2016","unstructured":"Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW et al. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol 2016; 73: 721\u2013732.","journal-title":"JAMA Neurol"},{"key":"BFsc201794_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcp.12617","volume":"80","author":"K Ruxton","year":"2015","unstructured":"Ruxton K, Woodman RJ, Mangoni AA . Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol 2015; 80: 209\u2013220.","journal-title":"Br J Clin Pharmacol"},{"key":"BFsc201794_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10286-013-0200-3","volume":"23","author":"R Sakakibara","year":"2013","unstructured":"Sakakibara R, Tateno F, Yano M, Takahashi O, Sugiyama M, Ogata T et al. Imidafenacin on bladder and cognitive function in neurologic OAB patients. Clin Auton Res 2013; 23: 189\u2013195.","journal-title":"Clin Auton Res"},{"key":"BFsc201794_CR10","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.juro.2013.06.036","volume":"190","author":"PW Veenboer","year":"2013","unstructured":"Veenboer PW, Huisman J, Chrzan RJ, Kuijper CF, Dik P, de Kort LM et al. Behavioral effects of long-term antimuscarinic use in patients with spinal dysraphism: a case control study. J Urol 2013; 190: 2228\u20132232.","journal-title":"J Urol"},{"key":"BFsc201794_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS . Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr 2015; 15: 31.","journal-title":"BMC Geriatr"},{"key":"BFsc201794_CR12","volume-title":"Revised Comprehensive Norms for an Expanded Halstead Reitan6 Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults","author":"RK Heaton","year":"2004","unstructured":"Heaton RK, Miller SW, Taylor MJ, Grant I . Revised Comprehensive Norms for an Expanded Halstead Reitan6 Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults. Psychological Assessment Resources, Inc: Lutz. 2004."},{"key":"BFsc201794_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/arclin\/acn001","volume":"24","author":"LM Binder","year":"2009","unstructured":"Binder LM, Iverson GL, Brooks BL . To err is human: \u2018abnormal\u2019 neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol 2009; 24: 31\u201346.","journal-title":"Arch Clin Neuropsychol"},{"key":"BFsc201794_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/sc.2010.172","volume":"49","author":"MJ DeVivo","year":"2011","unstructured":"DeVivo MJ, Biering-Sorensen F, New P, Chen Y . Standardization of data analysis and reporting of results from the International Spinal Cord Injury Core Data Set. Spinal Cord 2011; 49: 596\u2013599.","journal-title":"Spinal Cord"},{"key":"BFsc201794_CR15","volume-title":"Nonparametric Analysis Of Longitudinal Data In Factorial Experiments","author":"E Brunner","year":"2002","unstructured":"Brunner E, Domhof S, Langer F . Nonparametric Analysis Of Longitudinal Data In Factorial Experiments. Wiley: New York. 2002."},{"key":"BFsc201794_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v050.i12","volume":"50","author":"K Noguchi","year":"2012","unstructured":"Noguchi K, Gel YR, Brunner E, Konietschke F . nparLD: an R software package for the nonparametric analysis of longitudinal data in factorial experiments. J Stat Soft 2012; 50: 1\u201323.","journal-title":"J Stat Soft"},{"key":"BFsc201794_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1532-5415.1998.tb01006.x","volume":"46","author":"IR Katz","year":"1998","unstructured":"Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D'Angelo K . Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc 1998; 46: 8\u201313.","journal-title":"J Am Geriatr Soc"},{"key":"BFsc201794_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.eururo.2006.03.057","volume":"50","author":"G Kay","year":"2006","unstructured":"Kay G, Crook T, Rekeda L, Lima R, Ebinger U, Arguinzoniz M et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006; 50: 317\u2013326.","journal-title":"Eur Urol"},{"key":"BFsc201794_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/14740330903260790","volume":"8","author":"KA Wesnes","year":"2009","unstructured":"Wesnes KA, Edgar C, Tretter RN, Bolodeoku J . Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg. Expert Opin Drug Saf 2009; 8: 615\u2013626.","journal-title":"Expert Opin Drug Saf"},{"key":"BFsc201794_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.ju.0000148963.21096.5d","volume":"173","author":"RB Lipton","year":"2005","unstructured":"Lipton RB, Kolodner K, Wesnes K . Assessment of cognitive function of the elderly population: effects of darifenacin. J Urol 2005; 173: 493\u2013498.","journal-title":"J Urol"},{"key":"BFsc201794_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3810\/pgm.2012.05.2543","volume":"124","author":"GG Kay","year":"2012","unstructured":"Kay GG, Maruff P, Scholfield D, Malhotra B, Whelan L, Darekar A et al. Evaluation of cognitive function in healthy older subjects treated with fesoterodine. Postgrad Med 2012; 124: 7\u201315.","journal-title":"Postgrad Med"},{"key":"BFsc201794_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1742-1241.2010.02449.x","volume":"64","author":"A Wagg","year":"2010","unstructured":"Wagg A, Verdejo C, Molander U . Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. Int J Clin Pract 2010; 64: 1279\u20131286.","journal-title":"Int J Clin Pract"},{"key":"BFsc201794_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","volume":"100","author":"P Abrams","year":"2007","unstructured":"Abrams P, Andersson KE . Muscarinic receptor antagonists for overactive bladder. BJU Int 2007; 100: 987\u20131006.","journal-title":"BJU Int"},{"key":"BFsc201794_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.acn.2004.12.003","volume":"20","author":"LJ Beglinger","year":"2005","unstructured":"Beglinger LJ, Gaydos B, Tangphao-Daniels O, Duff K, Kareken DA, Crawford J et al. Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsychol 2005; 20: 517\u2013529.","journal-title":"Arch Clin Neuropsychol"},{"key":"BFsc201794_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2202-11-118","volume":"11","author":"C Bartels","year":"2010","unstructured":"Bartels C, Wegrzyn M, Wiedl A, Ackermann V, Ehrenreich H . Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci 2010; 11: 118.","journal-title":"BMC Neurosci"},{"key":"BFsc201794_CR26","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.pmrj.2011.05.007","volume":"3","author":"E Whyte","year":"2011","unstructured":"Whyte E, Skidmore E, Aizenstein H, Ricker J, Butters M . Cognitive impairment in acquired brain injury: a predictor of rehabilitation outcomes and an opportunity for novel interventions. PM R 2011; 3: S45\u2013S51.","journal-title":"PM R"},{"key":"BFsc201794_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/apmr.2002.32739","volume":"83","author":"RJ Heruti","year":"2002","unstructured":"Heruti RJ, Lusky A, Dankner R, Ring H, Dolgopiat M, Barell V et al. Rehabilitation outcome of elderly patients after a first stroke: effect of cognitive status at admission on the functional outcome. Arch Phys Med Rehabil 2002; 83: 742\u2013749.","journal-title":"Arch Phys Med Rehabil"},{"key":"BFsc201794_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1089\/neu.2016.4632","volume":"34","author":"A Craig","year":"2017","unstructured":"Craig A, Guest R, Tran Y, Middleton J . Cognitive impairment and mood states after spinal cord injury. J Neurotrauma 2017; 34: 1156\u20131163.","journal-title":"J Neurotrauma"},{"key":"BFsc201794_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ejpain.2008.06.003","volume":"13","author":"K Nicholson Perry","year":"2009","unstructured":"Nicholson Perry K, Nicholas MK, Middleton J . Spinal cord injury-related pain in rehabilitation: a cross-sectional study of relationships with cognitions, mood and physical function. Eur J Pain 2009; 13: 511\u2013517.","journal-title":"Eur J Pain"},{"key":"BFsc201794_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0003-9993(85)90148-0","volume":"66","author":"CB Wilmot","year":"1985","unstructured":"Wilmot CB, Cope DN, Hall KM, Acker M . Occult head injury: its incidence in spinal cord injury. Arch Phys Med Rehabil 1985; 66: 227\u2013231.","journal-title":"Arch Phys Med Rehabil"},{"key":"BFsc201794_CR31","first-page":"989","volume":"34","author":"J Wu","year":"2014","unstructured":"Wu J, Zhao Z, Sabirzhanov B, Stoica BA, Kumar A, Luo T et al. Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways. J Neurosci 2014; 34: 989\u20131006.","journal-title":"J Neurosci"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sc201794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sc201794","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/sc.2017.94","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/sc201794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:33:00Z","timestamp":1684621980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sc201794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["BFsc201794"],"URL":"https:\/\/doi.org\/10.1038\/sc.2017.94","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]},"assertion":[{"value":"27 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}